1. Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
   Jerry H. Houl et al, 2019, Nature Communications CrossRef
2. In Situ Nanofiber Patch Boosts Postoperative Hepatocellular Carcinoma Immune Activation by Trimodal Combination Therapy
   Yanan Zhao et al, 2024, ACS Nano CrossRef
3. Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
   José Yélamos et al, 2020, Cancers CrossRef
4. Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases
   Ping Huang et al, 2022, International Journal of Molecular Sciences CrossRef
5. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
   Daniel Harrision et al, 2020, Frontiers in Molecular Biosciences CrossRef
6. PARG Promotes Esophagus Cancer Cell Metastasis by Activation of the Wnt/β-Catenin Pathway
   Jiaxin Yan et al, 2024, Biochemical Genetics CrossRef